Skip to main content
Clinical Trials/NCT03438383
NCT03438383
Completed
Not Applicable

The Effect of Bi-PAP at Individualized Pressures on the Postoperative Pulmonary Recovery of Morbidly Obese Patients (MOP) Undergoing Open Bariatric Surgery (OBS) and Possible Placebo Device-related Effects (Sham-Bi-PAP)

Evangelismos Hospital0 sites48 target enrollmentMay 23, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atelectasis
Sponsor
Evangelismos Hospital
Enrollment
48
Primary Endpoint
Forced Expiratory Volume at One Second (FEV1) Difference
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The effect of biphasic positive airway pressure (Bi-PAP) at individualized pressures on the postoperative pulmonary recovery of morbidly obese patients (MOP) undergoing open bariatric surgery (OBS) and possible placebo device-related effects (sham-Bi-PAP) were investigated.

Detailed Description

In the present study the effect of Bi-PAP on the postoperative respiratory function and related complications of MOP undergoing OBS through a randomized sham-controlled design was investigated. Bi-PAP was applied at individualized pressures in order to optimize respiratory support and sham Bi-PAP was also used in order to neutralize possible placebo device related effect and researcher related bias. The investigators hypothesized that the use of Bi-PAP at individualized pressures in MOP undergoing OBS, ameliorates postoperative respiratory function as well as diminishes related pulmonary complications, postoperative pain and duration of hospitalization. Primary endpoints were the difference in pre- and postoperative measurements of certain pulmonary function parameters (forced expiratory volume at one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR) and oxygen saturation by pulse oximetry (SpO2) and the incidence of certain pulmonary complications postoperatively (hypoxemia, atelectasis, lower respiratory tract infections). Secondary endpoints were postoperative pain and days of hospitalization.

Registry
clinicaltrials.gov
Start Date
May 23, 2011
End Date
May 31, 2012
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Evangelismos Hospital
Responsible Party
Principal Investigator
Principal Investigator

Alexandropoulou N. Aikaterini

Consultant

Evangelismos Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients have been Morbidly Obese (BMI\> 40kg/m2) for at least 10 years
  • All patients had unsuccessfully tried to lose weight by other non-invasive means.
  • All patients enrolled were continuous positive airway pressure (CPAP) and Bi-PAP naïve and had no knowledge about the Bi-PAP apparatus prior to enrollment
  • All patients underwent OBS (gastroplasty by Mason or gastric bypass) by the same operating team
  • All patients were treated with the same standard anesthetic protocol

Exclusion Criteria

  • Cardiovascular and pulmonary disease not related to obesity status
  • Chronic renal disease
  • Patients who were initially enrolled but did not use the allocated device (Bi-PAP or Sham Bi-PAP) for at least 12 h daily were also excluded at a later point.

Outcomes

Primary Outcomes

Forced Expiratory Volume at One Second (FEV1) Difference

Time Frame: 24 h before surgery and at 24, 48 and 72 h post-operatively

difference in FEV1 value measured by spirometry pre- and post-operatively

Forced Vital Capacity (FVC) Difference

Time Frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively

difference in FVC value measured by spirometry pre- and post-operatively

Peak Expiratory Flow Rate (PEFR) Difference

Time Frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively

difference in PEFR value measured by spirometry pre- and post-operatively

SpO2 Difference

Time Frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively

difference in SpO2 value measured by spirometry pre- and post-operatively

Number of Participants With Hypoxemia

Time Frame: At 24, 48 and 72 hours post-operatively

occurrence of hypoxemia, considered as SpO2\<90%, post-operatively

Number of Participants With Atelectasis

Time Frame: At 24, 48 and 72 hours post-operatively

occurrence of atelectasis as defined by chest X-ray (CXR) post-operatively with CXR before surgery as baseline

Secondary Outcomes

  • Post-operative Pain(right before spirometry, at 24, 48 and 72 h post-operatively)
  • Days of Hospitalization(From day of admission to day of discharge from the hospital)

Similar Trials